Insulet beats quarterly profit estimates on insulin pump demand
Insulet reported a higher-than-expected profit in the fourth quarter on Thursday, driven by strong demand for its wearable insulin pumps.
FDA approves first rapid-acting insulin biosimilar for patients with diabetes
Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...
Medical News Today15h
Artificial sweetener may increase heart disease risk by triggering insulin surges
A common artificial sweetener may trigger insulin spikes that lead to the build up of fatty plaques in the arteries, ...
Public News Service on MSN19h
Schools struggle to keep up with diabetes tech, leaving parents to fill gaps
By Phil Galewitz for KFF Health News. Broadcast version by Trimmel Gomes for Florida News Connection reporting for the KFF Health News-Public News Service Collaboration Just a few years ago, children ...